Cite
HARVARD Citation
Ungefroren, H. (n.d.). Blockade of TGF-β signaling: a potential target for cancer immunotherapy?. Expert opinion on therapeutic targets. pp. 679-693. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Ungefroren, H. (n.d.). Blockade of TGF-β signaling: a potential target for cancer immunotherapy?. Expert opinion on therapeutic targets. pp. 679-693. [Online].